Life Sciences 1996-01-01

Morin hydrate inhibits azo-initiator induced oxidation of human low density lipoprotein.

T W Wu, K P Fung, J Wu, C C Yang, J Lo, R D Weisel

Index: Life Sci. 58 , PL17-PL22, (1996)

Full Text: HTML

Abstract

We demonstrated that the flavonoid morin hydrate at 75-100 microM protects against the oxidation of low density lipoprotein (LDL) by free radicals produced by 2,2'-azo-bis(2-amidinopropane) dihydrochloride. Morin hydrate reduces the relative electrophoretic mobility, malondialdehyde equivalents and lipid peroxide level of oxidized LDL. On the other hand, Trolox (an analogue of vitamin E) showed less protective effect in the present system. Since free radical mediated oxidation of LDL is implicated to be a cause of atherogenesis, morin hydrate may be a candidate chemotherapeutic agent herein.

Related Compounds

  • morin r. g.

Related Articles:

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.

2014-11-19

[Sci. Transl. Med. 6(263) , 263ra161, (2014)]

Morin hydrate augments phagocytosis mechanism and inhibits LPS induced autophagic signaling in murine macrophage.

2014-10-01

[Int. Immunopharmacol. 22(2) , 356-65, (2014)]

Drug screening boosted by hyperpolarized long-lived states in NMR.

2014-11-01

[ChemMedChem 9(11) , 2509-15, (2014)]

Al adjuvants can be tracked in viable cells by lumogallion staining.

2015-07-01

[J. Immunol. Methods 422 , 87-94, (2015)]

Molecular properties and myocardial salvage effects of morin hydrate.

1995-02-14

[Biochem. Pharmacol. 49 , 537-543, (1995)]

More Articles...